Efficacy and Safety of Sequential Hormone Therapy and Tetuzumab Therapy in Patients With Moderate to Severe TAO in the Active Stage After Glucocorticoid Treatment.

NCT07152366 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

96

Enrollment

OTHER

Sponsor class

Conditions

Thyroid Associated Ophthalmopathies

Interventions

DRUG: IBI311
DRUG: Glucocorticoids

Sponsor

Shanghai Changzheng Hospital